Veterinary Medicine Information website

GLETVAX 6 Injektionssuspension für Schweine

Authorised
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F6
Download as PDF

Product identification

Medicine name:
GLETVAX 6 Injektionssuspension für Schweine
Active substance:
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F6
Target species:
  • Pig (sow for reproduction)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type B and C, beta toxoid
    300.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium perfringens, type D, epsilon toxoid
    200.00
    international unit(s)
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ab
    14.60
    log2 antibody titre
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ac
    15.50
    log2 antibody titre
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F5
    12.20
    log2 antibody titre
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F6
    13.10
    log2 antibody titre
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (sow for reproduction)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Pig (sow for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 254a/94
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/09/2025
Download